Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.

Sanofi announces today the filing of its Form 20-F with the ... and the “Document d’Enregistrement Universel” is available on the website of the AMF (www.amf-france.org). A hard copy of these ...

In October 2023, Sanofi entered into an agreement with Janssen Pharmaceuticals, Inc. (Janssen), a Johnson & Johnson company to develop and commercialize the vaccine candidate. Under the terms of the ...

For instance, many wonder if they can change the boot logo in Windows 10. By default, every time you boot the OS, a Windows logo appears on the screen with a few dots spinning in a circle which ...

OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. OpenAI’s big rebranding effort brings a new logo and a new typeface, OpenAI sans. Emma Roth is a news writer ...

Sales of anti-inflammatory drug Dupixent rose 15% to $3.7 billion. The French partner, Sanofi, records Dupixent's sales and the profits are split equally between the companies. Its skin cancer ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Starting a new job search? Take the first step with these ...

“Unfortunately, Brett was diagnosed with thyroid cancer toward the end of last year, around our one-year wedding anniversary,” she said in a confessional. “I thought, like, how? Like, I’m ...

L’Oreal OR0.83%increase; green up pointing triangle will sell part of its stake in Sanofi SAN-0.46%decrease; red down pointing triangle back to the French pharmaceutical company for 3 billion ...

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

AdvanCell has secured $112 million in a Sanofi Ventures-backed series C funding round as the Australian radiopharma company takes its lead candidate through a prostate cancer trial. The Pb-212 ...

Sanofi has bought back a €3bn ($3.1bn) stake held by cosmetics giant L'Oréal, the first of multiple share buybacks the French drugmaker has planned for 2025. L'Oréal was selling 29,556,650 ...